News

KAF News

Kate Amato Foundation awards $75K in grants for pediatric cancer research

The Kate Amato Foundation is continuing to honor Childhood Cancer Awareness Month this September with two major announcements.
The foundation is awarding $75,000 to fund two groundbreaking pediatric cancer research projects. In addition, it has launched Kate’s Kindness Project, which provides immediate direct support to local children hospitalized with cancer.

Read More
KAF News

Foundation helping fund cancer research

The Kate Amato Foun- dation (KAF) is continu- ing to honor Childhood Cancer Awareness Month this September with two announcements. They are awarding $75,000 to fund two pediatric cancer research projects, which serves the organization’s mission. The organization has also launched Kate’s Kindness Project, which provides immediate direct support to local children hospitalized with cancer.

Read More
KAF News

Kate Amato Foundation awards $75,000 in grants for pediatric cancer research

The Kate Amato Foundation continues to honor Childhood Cancer Awareness Month this September with two exciting announcements. The foundation has awarded $75,000 to fund two groundbreaking pediatric cancer research projects. The group has also launched Kate’s Kindness Project, which provides immediate direct support to local children hospitalized with cancer.

Read More
Research News

Childhood Cancer Research Team at Nationwide Children’s Hospital Awarded $10.2 Million Moonshot Grant

COLUMBUS, Ohio – The National Cancer Institute at the National Institutes of Health announced it has awarded one of its Cancer Moonshot grants to Timothy Cripe, MD, PhD, chief of the division of Hematology, Oncology & Blood and Marrow Transplant and Elaine Mardis, PhD, co-executive director of the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital.

Read More
Research News

Anti-inflammatory strategy could lead to improved survival of children with neuroblastoma

Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumor stroma reduces tumor growth in experimental neuroblastoma models. The findings are published in EBioMedicine and open for new treatment strategies for this aggressive childhood cancer.

Read More